Seoul, January 20, 2026 – JMK Token, a utility token designed to support the global stem cell industry, has announced the start of its second presale stage, now priced at $0.10 per token. The presale aims to raise funds to support the project’s ongoing expansion into healthcare, agriculture, tourism, and regulated financial services.
Bridging Blockchain and Biotech
JMK Token is more than a digital asset—it serves as the backbone of a growing ecosystem that combines blockchain technology with real-world applications. Initially focused on global stem cell treatment centers, the platform now integrates:
Global Stem Cell Clinics & Labs: Patient care, research, post-treatment follow-up, and medical tourism integration.
Presale Details
Roadmap Highlights
Strategic Vision
JMK Token positions itself as a utility-first ecosystem token, enabling payments, access, and fee reductions across multiple sectors while maintaining strict regulatory compliance. Funds raised during the presale will support research and development, ecosystem growth, liquidity, and marketing.
“The strong community support and early-stage engagement demonstrate the demand for a multi-industry utility token like JMK,” said Kim Ho Woo (CEO JMK Korea). “We’re excited to expand our ecosystem and bring blockchain innovation to healthcare, agriculture, tourism, and trading services worldwide.”
About JMK Token
JMK Token is a digital utility token powering a comprehensive ecosystem focused on regenerative medicine, AI agriculture, tourism experiences, and regulated trading. By integrating blockchain with real-world applications, JMK aims to drive adoption and innovation globally.
JMK Korea Media Contact
Email: support@jmkstemcell.ai
Website: www.jmkstemcell.ai